Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type Interaction Map description Network Comparison Type Rank Gene Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 482 to 531 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calnexin precursor (major histocompatibility complex class i antigen-binding protein p88) (p90) (ip90). [source:swissprot;acc:p27824]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1474\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5910.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6355.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0753\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calpain 1, large [catalytic] subunit (ec 3.4.22.17) (calcium-activated neutral proteinase) (canp) (mu-type) (mucanp) (micromolar-calpain). [source:swissprot;acc:p07384]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2384\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4164.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4336.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04129\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calpain 2, large [catalytic] subunit precursor (ec 3.4.22.17) (calcium-activated neutral proteinase) (canp) (m-type) (m-calpain) (millimolar-calpain) (calpain large polypeptide l2). [source:swissprot;acc:p17655]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2383\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4164.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4337.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04136\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calreticulin precursor (crp55) (calregulin) (hacbp) (erp60). [source:swissprot;acc:p27797]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1526\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5369.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5763.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0735\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calsyntenin-1 precursor. [source:swissprot;acc:o94985]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
536\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10603.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12069.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13826\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calsyntenin-2 precursor. [source:swissprot;acc:q9h4d0]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
541\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10600.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12065.2\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.13819\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
calsyntenin-3 precursor. [source:swissprot;acc:q9bqt9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
543\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10599.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12064.7\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
camp response element-binding protein cre-bpa. [source:refseq;acc:nm\_004904]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1439\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5658.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6093.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07683\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
camp responsive element binding protein-like 2. [source:refseq;acc:nm\_001310]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3078\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
camp-dependent protein kinase type i-alpha regulatory chain (tissue- specific extinguisher-1) (tse1). [source:swissprot;acc:p10644]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3089\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
camp-dependent protein kinase type ii-alpha regulatory chain. [source:swissprot;acc:p13861]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1710\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5916.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6321.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06857\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
camp-dependent protein kinase type ii-beta regulatory chain. [source:swissprot;acc:p31323]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1715\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5918.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6323.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06849\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
camp-dependent protein kinase, alpha-catalytic subunit (ec 2.7.1.37) (pka c-alpha). [source:swissprot;acc:p17612]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1714\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5917.23\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6322.73\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06853\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
camp-dependent protein kinase, beta-catalytic subunit (ec 2.7.1.37) (pka c-beta). [source:swissprot;acc:p22694]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1713\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
camp-dependent protein kinase, gamma-catalytic subunit (ec 2.7.1.37) (pka c-gamma). [source:swissprot;acc:p22612]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1712\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
candidate tumor suppressor in ovarian cancer 2. [source:refseq;acc:nm\_080822]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2025\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4813.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5091.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05781\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
carboxypeptidase a1 precursor (ec 3.4.17.1). [source:swissprot;acc:p15085]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2351\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
8353.97\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
8001.45\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04406\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
carboxypeptidase a5. [source:refseq;acc:nm\_080385]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2344\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
carboxypeptidase b precursor (ec 3.4.17.2) (pancreas-specific protein) (pasp). [source:swissprot;acc:p15086]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2345\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
carboxypeptidase b precursor. [source:refseq;acc:nm\_020361]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
239\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7711.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6265.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.23071\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
carboxypeptidase h precursor (ec 3.4.17.10) (cph) (carboxypeptidase e) (cpe) (enkephalin convertase) (prohormone processing carboxypeptidase). [source:swissprot;acc:p16870]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
719\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6593.17\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7364.55\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.117\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
carboxypeptidase n catalytic chain precursor (ec 3.4.17.3) (arginine carboxypeptidase) (kininase 1) (serum carboxypeptidase n) (scpn) (anaphylatoxin inactivator) (plasma carboxypeptidase b). [source:swissprot;acc:p15169]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
717\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
carcinoma related gene. [source:refseq;acc:nm\_016041]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3179\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
carnitine o-acetyltransferase (ec 2.3.1.7) (carnitine acetylase) (cat). [source:swissprot;acc:p43155]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1093\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5791.05\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6316.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09075\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
carnitine o-palmitoyltransferase ii, mitochondrial precursor (ec 2.3.1.21) (cpt ii). [source:swissprot;acc:p23786]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2885\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cartilage oligomeric matrix protein precursor (comp). [source:swissprot;acc:p49747]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2220\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3936.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3755.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04816\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase i alpha s-like. [source:refseq;acc:nm\_145203]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
953\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4906.33\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5382.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09705\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase i, alpha isoform (ec 2.7.1.-) (cki-alpha) (ck1). [source:swissprot;acc:p48729]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
954\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase i, delta isoform (ec 2.7.1.-) (cki-delta) (ckid). [source:swissprot;acc:p48730]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1035\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5054.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5530.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09407\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase i, epsilon isoform (ec 2.7.1.-) (cki-epsilon) (ckie). [source:swissprot;acc:p49674]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1030\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5048.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5523.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09419\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase i, gamma 1 isoform (ec 2.7.1.-) (cki-gamma 1). [source:swissprot;acc:q9hcp0]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2830\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase i, gamma 2 isoform (ec 2.7.1.-) (cki-gamma 2). [source:swissprot;acc:p78368]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2986\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase i, gamma 3 isoform (ec 2.7.1.-) (cki-gamma 3). [source:swissprot;acc:q9y6m4]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2901\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase ii beta chain (ck ii) (phosvitin) (g5a). [source:swissprot;acc:p13862]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1245\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4835.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5243.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08431\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase ii, alpha chain (ck ii) (ec 2.7.1.37). [source:swissprot;acc:p19138]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
851\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4307.12\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4755.03\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.10399\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase ii, alpha' chain (ck ii) (ec 2.7.1.37). [source:swissprot;acc:p19784]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
852\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
caspase-7 precursor (ec 3.4.22.-) (ice-like apoptotic protease 3) (ice-lap3) (apoptotic protease mch-3) (cmh-1). [source:swissprot;acc:p55210]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
948\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4633.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5084.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09728\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
catenin (cadherin-associated protein), alpha-like 1; alpha-catulin. [source:refseq;acc:nm\_003798]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
616\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
11222.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9948.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12798\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cathepsin b precursor (ec 3.4.22.1) (cathepsin b1) (app secretase). [source:swissprot;acc:p07858]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
914\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6513.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7161\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09942\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cathepsin l precursor (ec 3.4.22.15) (major excreted protein) (mep). [source:swissprot;acc:p07711]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2238\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5902.27\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6181.21\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04726\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
cathepsin l2 precursor (ec 3.4.22.43) (cathepsin v) (cathepsin u). [source:swissprot;acc:o60911]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2237\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5902.26\vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
caveolin-1. [source:swissprot;acc:q03135]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3099\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
caveolin-3 (m-caveolin). [source:swissprot;acc:p56539]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2779\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cbf1 interacting corepressor. [source:refseq;acc:nm\_004882]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1651\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5944.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6358.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06962\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cbl e3 ubiquitin protein ligase (ec 6.3.2.-) (signal transduction protein cbl) (proto-oncogene c-cbl). [source:swissprot;acc:p22681]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
507\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6875.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7858.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14302\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ccaat displacement protein (cdp) (cut-like 1). [source:swissprot;acc:p39880]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
257\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6417.31\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7858.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.22452\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ccaat-binding transcription factor subunit b (cbf-b) (nf-y protein chain a) (nf-ya) (caat-box dna binding protein subunit a). [source:swissprot;acc:p23511]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
137\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3620.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4763.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.31556\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ccaat-box-binding transcription factor (ccaat-binding factor) (cbf). [source:swissprot;acc:q03701]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
369\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3583.56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4194.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17061\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ccr4-not transcription complex, subunit 3; not3 (negative regulator of transcription 3, yeast) homolog. [source:refseq;acc:nm\_014516]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3163\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ccr4-not transcription complex, subunit 4; not4 (negative regulator of transcription 4, yeast) homolog; ccr4-not transcription complex, subunit. [source:refseq;acc:nm\_013316]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2289\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5783.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6048.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04585\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/